WisdomTree (NYSE:WT – Get Free Report)‘s stock had its “outperform” rating reissued by equities researchers at Oppenheimer in a research note issued on Monday, Benzinga reports. They currently have a $11.00 target price on the stock. Oppenheimer’s price target indicates a potential upside of 23.60% from the company’s previous close.
WT has been the subject of a number of other reports. Northland Securities raised shares of WisdomTree from a “market perform” rating to an “outperform” rating and set a $12.00 price objective for the company in a research note on Wednesday, April 3rd. Morgan Stanley raised their price target on WisdomTree from $7.75 to $9.25 and gave the stock an “equal weight” rating in a research report on Wednesday, April 17th. UBS Group increased their price objective on WisdomTree from $9.00 to $12.00 and gave the company a “buy” rating in a research note on Friday, April 12th. Finally, Craig Hallum initiated coverage on shares of WisdomTree in a research note on Wednesday, March 6th. They issued a “buy” rating and a $12.00 target price for the company. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $10.88.
Get Our Latest Stock Report on WisdomTree
WisdomTree Stock Down 0.2 %
WisdomTree (NYSE:WT – Get Free Report) last issued its quarterly earnings data on Friday, April 26th. The company reported $0.12 EPS for the quarter, beating analysts’ consensus estimates of $0.11 by $0.01. The firm had revenue of $96.84 million for the quarter, compared to analysts’ expectations of $94.32 million. WisdomTree had a net margin of 29.80% and a return on equity of 16.31%. The firm’s revenue was up 18.0% on a year-over-year basis. During the same period in the prior year, the company earned $0.07 EPS. Analysts anticipate that WisdomTree will post 0.52 EPS for the current fiscal year.
Insider Activity at WisdomTree
In related news, CEO Jonathan L. Steinberg acquired 303,781 shares of the business’s stock in a transaction dated Tuesday, February 13th. The shares were acquired at an average cost of $7.20 per share, for a total transaction of $2,187,223.20. Following the acquisition, the chief executive officer now directly owns 9,172,838 shares in the company, valued at approximately $66,044,433.60. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 7.80% of the company’s stock.
Institutional Trading of WisdomTree
Institutional investors have recently made changes to their positions in the stock. Quantbot Technologies LP purchased a new stake in shares of WisdomTree during the 3rd quarter worth about $26,000. Avior Wealth Management LLC purchased a new stake in WisdomTree during the fourth quarter worth approximately $40,000. Allspring Global Investments Holdings LLC acquired a new stake in shares of WisdomTree in the fourth quarter worth $46,000. Simplex Trading LLC purchased a new position in shares of WisdomTree in the 4th quarter valued at $55,000. Finally, KBC Group NV acquired a new position in shares of WisdomTree during the 3rd quarter valued at $62,000. 78.64% of the stock is owned by hedge funds and other institutional investors.
WisdomTree Company Profile
WisdomTree, Inc, through its subsidiaries, operates as an exchange-traded funds (ETFs) sponsor and asset manager. It offers ETFs in equities, currency, fixed income, and alternatives asset classes. The company also licenses its indexes to third parties for proprietary products, as well as offers a platform to promote the use of WisdomTree ETFs in 401(k) plans.
See Also
- Five stocks we like better than WisdomTree
- The How and Why of Investing in Gold Stocks
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- What Are Dividend Champions? How to Invest in the Champions
- Hilton Demonstrates Asset Light is Right for Investors
- Basic Materials Stocks Investing
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for WisdomTree Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WisdomTree and related companies with MarketBeat.com's FREE daily email newsletter.